Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT03468439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital | Gaziler Physical Medicine and Rehabilitation, Training and Research Hospital, Department of PMR | SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Active Ingredients

Drugs in Other Trials (3)

lidocaine (xylocaine) (1 trial)

phenol (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3